LIFESTYLE DELIVERY SYS. WKN: A14XHT ISIN: CA53224Y1043 Kürzel: LD6 Forum: Aktien Thema: Hauptdiskussion

Wäre die Transen Nummer nicht gewesen hätte ich auf aktuellem Niveau gerne nochmal nachgelegt, aber jetzt hab ich keinen Bock mehr noch mehr zu versenken hier!!

Ja, kann ich auch nicht verstehen und würde die Anleger etwas beruhigen und den Kurs vllt stabilisieren

Die Hoffnung stirbt zuletzt. Anstatt die mal was offizielles raushauen nach dem geplatzten Deal mit TransCanna.....richtig amateurhaft

In der Fuac ebo ok *** hat der Vik nun einen umfassenden Bericht geschrieben. Er war ja Mittwoch dort mit 2 anderen Investoren. Beim Management scheint es personell wohl keine Veränderungen zu geben. Nur wieder Hoffnungen und so weiter ubd sofort.....

Bisschen Hoffnung könnte aufkeimen wenn das Management sich wieder besinnt. Produktion scheint ja zu laufen und vik mischt sich ein. Trotzdem nervt es dass man keine offizielle Strategie hört oder Umsätze etc.

https://www.face..book.com/groups/205800509984726/permalink/461632634401511/

Soweit ich weiß ist morgen ein Treffen von zwei größeren shareholdern mit denen

Wenn das Management nicht so ultimativ schlecht wäre...

Endlich mal wieder gute News. Vllt geht doch wieder was

@ruffmybubble Danke

https://static1.squarespace.com/static/5b5fb77f9772ae6ed9884719/t/5d373231ec962c00011bcdf2/1563898417956/19-07-23_LDS+NR+CannaStripsTM+now+in+a+Total+of+42+Dispensaries_Final.pdf

@newswire/california-consumer-access-to-cannastrips-now-in-achannel by @newswire on 23 Jul 2019, 05:00 California Consumer Access to CannaStrips™ Now in a Total of 42 Dispensaries VANCOUVER, British Columbia, July 23, 2019 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces 10 additional dispensaries as CSPA Group, Inc., the Company's wholly-owned subsidiary, continues to expand the availability of its flagship product, CannaStrips™, within the Californiamarket. CannaStrips™ availability continues to grow as planned and the positive consumer feedback is great to hear as the Company gains additional exposure in the recreational market throughout California.  The Company continues to identify industry influencers and potential collaborative partners to realize the market potential of its discreet and effective CannaStrips™.  CSPA's team holds vendor days, trains retailers, and educates budtenders about the vast advantages that CannaStrips™ have over anything else on the store shelf.  Casey Fenwick, the President of LDS, stated, "We are seeing the benefits of our customer focussed approach as the educated retailers and customers recommend our product thereby increasing sales and the speed of reorders.  The affordability of CannaStrips™ immediately removes any consumer purchase apprehension and encourages traditional cannabis consumers to explore a new product and realize the social benefits of adding CannaStrips™ to their cannabis use.  Continuing to gain market awareness is hugely beneficial as we approach critical mass and full market acceptance of CannaStrips™. The feedback from consumers is very positive on efficacy, ease of use, discretion and ability to use the product in nearly any social setting."  Below are 10 new dispensaries carrying CannaStrips™: Patient Care First Phenos Doctors Choice Silverstreak Delivery Honest Choice The Higher Conscience The Peoples Remedy (McHenry) LA Kush Safe Capitol Compassion Co-Op LPC Delivery About CSPA Group Inc.  CSPA Group, Inc. is located in Adelanto, California and is a City-Permitted and State-Licensed manufacturer and distributor/transporter in the California cannabis industry. CSPA Group manufactures extracted oils and distillates, and producing CannaStrips™ under a license agreement with Lifestyle Delivery Systems Inc., a British Columbia corporation. About CannaStrips™ CannaStrips™ is formulated oral strip for effective buccal mucosal delivery that disrupts the barrier created by saliva coating the mucosal membrane for the active materials (in this case cannabinoids) which have been nanoparticulated and encapsulated to penetrate the multiple layers of mucosal and sub-mucosal membranes to the blood stream.  Once in the blood stream the encapsulation is undetectable as a foreign material by the liver. This undetectability allows the material to avoid being filtered out of the blood stream by the liver. The encapsulation also is more effective in penetrating the blood-brain barrier and allowing for greater bioavailability and extending the effective time from a single dose.

Komisch. Bei mir funktionierts.. hier mal rauskopiert

@ruffybubble leider ist der link nicht zu öffnen

https://ceo.ca/@newswire/california-consumer-access-to-cannastrips-now-in-a

Sind wir bald bei Null angekommen. Naja mal sehen was daraus wird.